Latest News

MMS Holdings and Sage IT Celebrate 10-Year Relationship with Deep Focus on Intelligent Automation and Bot Development

CANTON, Mich. and FRISCO, Texas (August 1, 2019) – MMS Holdings – an award-winning, data-focused CRO – announced that today marks 10 years of successful partnership with Sage IT—a premier provider, helping companies operationalize their vision through the enhancement or development of innovative technology solutions.

This partnership, with emphasis on Intelligent Automation, has focused plans for deliverables in the near future; in particular:

  • Leveraging artificial intelligence (AI) and (NLP) for document development and authoring
  • Developing tools that bring efficiencies to pharmaceutical and biotech sponsors
  • Using automation to achieve Operational Excellence
  • Focusing on a “we is better than me” approach, where MMS technologies work alongside, or directly, with innovative sponsor tools to magnify efficiencies

“MMS plays a key role in bringing innovative and much-needed therapies to the marketplace, and because of this, we work to operate with a sense of urgency. As experts in pharmaceutical services, MMS is well-poised to now include the latest technology with IT expertise from Sage IT. Intelligent automation and bot development through this relationship will allow clinical trial sponsor teams to be more productive; shifting their focus to decision making versus the processing steps involved in data collection, analysis, and reporting,” said Kelly J. Hill, Executive Director, Global Project & Account Management, MMS Holdings.

“We are consistently pushing ourselves and our teams to revisit the old way and create innovative, new paths in the industry, and this is just one of the many ways that MMS is redefining the CRO experience,” HIll added.

“In this industry, you can’t slow down, and this mutually-beneficial relationship between MMS and Sage IT reflects the strong values, rigorous selection process, high standards, and clear communications that have maintained the partnership over the past decade,” said Aravind Kashyap, CEO, Sage IT. “Our goal is to make human and machine interaction smart through cognitive automation, and together MMS and Sage IT are accomplishing that.”

Implementation and measuring productivity

Last month, MMS released Automatiqc® as a configurable tool to improve document quality and reduce the time for report development through the use of intelligent automation (IA). This was one of the many technological successes supported by the partnership with Sage IT.

“Measuring productivity in the pharmaceutical service industry is critical. Building efficiencies to reduce drug development costs have been an industry focus for a long time, and there is a need to quantify the value added by these innovations, or where there is resistance, the impact of delaying the implementation of an innovative service model or technology,” said Hill. “Key performance indicators (KPIs) related to productivity are a key in driving smart changes. These KPIs need to be clearly defined in a way that is meaningful to the functional lines, offering transparency into the process and resulting in actionable takeaways.”

Innovations related to clinical trial data planning, collection, analysis, and reporting has been a focus at MMS since inception in 2006. For more details, visit: www.mmsholdings.com

About MMS Holdings

MMS is an award-winning, data-focused CRO that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience and a data-driven approach to drug development make MMS a valuable CRO partner, creating compelling submissions that meet rigorous regulatory standards. With a global footprint across four continents, MMS maintains a 97 percent customer satisfaction rating, and the company was named Most Outstanding CRO in the 2019 Biotechnology Awards and Best Global CRO in the 2018 International Life Sciences Awards. For more information, visit www.mmsholdings.com or follow MMS on LinkedIn.

About Sage IT

Sage IT is a premier provider of innovative information technology solutions, products, and services. As a dynamic IT services company, Sage IT has the right people, processes, and technology for every aspect of a business solution. Sage IT offers comprehensive Cognitive Automation, Digital Modernization and Customer Interaction services with focus on application integration, application development, cloud migration and cloud adoption, technology consulting, implementation, application support services and professional services for companies all over the US, UK and India. These services are offered through a unique onsite, offsite, offshore delivery model that helps our customers achieve rapid implementation, world-class quality and reduced costs. Visit Sage IT at https://www.sageitinc.com or follow them on LinkedIn.

Suggested For You

news

November 19th, 2024

MMS Recognized as a Top Workplace by Detroit Free Press and USA Today Network for the Fourth Consecutive Year

news

November 8th, 2024

MMS Named a Finalist in the 2024 Fierce CRO Awards for Leadership in Regulatory Compliance

news

October 15th, 2024

MMS Recognized with EcoVadis Bronze Medal for Leadership in ESG Sustainability Efforts as a Leading Clinical Research Organization (CRO)

news

July 17th, 2024

Industry Veteran Ben Dudley Joins MMS as Chief Commercial Officer (CCO) to Drive Continued Growth for the Data-focused Clinical Research Organization

news

April 4th, 2024

MMS Hires Pharmaceutical Industry Veteran James Zee for Global Biometrics Leadership in Europe Amid Strong Regional Growth

news

March 6th, 2024

MMS Holdings Inc – A Data-Centric CRO Powerhouse Reshaping Drug Development on a Global Scale

news

December 13th, 2023

MMS Supported Lykos Therapeutics: NDA Submitted to FDA for First Psychedelic-Assisted Therapy for PTSD

news

April 18th, 2023

MMS Named Great Place to Work in the UK as Growth in the Region Doubles

news

March 21st, 2023

MMS Scientific Advisory Board’s New Members Expand CRO’s Therapeutic Expertise

news

February 21st, 2023

MMS Partners with I-ACT to Advance Children’s Clinical Trials

news

February 7th, 2023

Award-Winning Data CRO Expands Executive Leadership to Support Company’s Next Stage of Growth

news

January 11th, 2023

MMS Named a Great Place to Work in India